151 related articles for article (PubMed ID: 16712967)
1. Cell line dependency for antiviral activity and in vivo efficacy of N-methanocarbathymidine against orthopoxvirus infections in mice.
Smee DF; Wandersee MK; Bailey KW; Wong MH; Chu CK; Gadthula S; Sidwell RW
Antiviral Res; 2007 Jan; 73(1):69-77. PubMed ID: 16712967
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of N-methanocarbathymidine in treating mice infected intranasally with the IHD and WR strains of vaccinia virus.
Smee DF; Hurst BL; Wong MH; Glazer RI; Rahman A; Sidwell RW
Antiviral Res; 2007 Nov; 76(2):124-9. PubMed ID: 17658623
[TBL] [Abstract][Full Text] [Related]
3. Treatment of lethal cowpox virus respiratory infections in mice with 2-amino-7-[(1,3-dihydroxy-2-propoxy)methyl]purine and its orally active diacetate ester prodrug.
Smee DF; Bailey KW; Sidwell RW
Antiviral Res; 2002 May; 54(2):113-20. PubMed ID: 12062396
[TBL] [Abstract][Full Text] [Related]
4. Cutaneous infections of mice with vaccinia or cowpox viruses and efficacy of cidofovir.
Quenelle DC; Collins DJ; Kern ER
Antiviral Res; 2004 Jul; 63(1):33-40. PubMed ID: 15196818
[TBL] [Abstract][Full Text] [Related]
5. Treatment of cowpox virus respiratory infections in mice with ribavirin as a single agent or followed sequentially by cidofovir.
Smee DF; Bailey KW; Sidwell RW
Antivir Chem Chemother; 2000 Jul; 11(4):303-9. PubMed ID: 10950392
[TBL] [Abstract][Full Text] [Related]
6. Antiviral activities and phosphorylation of 5-halo-2'-deoxyuridines and N-methanocarbathymidine in cells infected with vaccinia virus.
Smee DF; Humphreys DE; Hurst BL; Barnard DL
Antivir Chem Chemother; 2008; 19(1):15-24. PubMed ID: 18610554
[TBL] [Abstract][Full Text] [Related]
7. Lack of efficacy of aurintricarboxylic acid and ethacrynic acid against vaccinia virus respiratory infections in mice.
Smee DF; Hurst BL; Wong MH
Antivir Chem Chemother; 2010 Apr; 20(5):201-5. PubMed ID: 20413827
[TBL] [Abstract][Full Text] [Related]
8. Characterization of wild-type and cidofovir-resistant strains of camelpox, cowpox, monkeypox, and vaccinia viruses.
Smee DF; Sidwell RW; Kefauver D; Bray M; Huggins JW
Antimicrob Agents Chemother; 2002 May; 46(5):1329-35. PubMed ID: 11959564
[TBL] [Abstract][Full Text] [Related]
9. Intranasal treatment of cowpox virus respiratory infections in mice with cidofovir.
Smee DF; Bailey KW; Wong M; Sidwell RW
Antiviral Res; 2000 Sep; 47(3):171-7. PubMed ID: 10974369
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of multiple- or single-dose cidofovir against vaccinia and cowpox virus infections in mice.
Quenelle DC; Collins DJ; Kern ER
Antimicrob Agents Chemother; 2003 Oct; 47(10):3275-80. PubMed ID: 14506041
[TBL] [Abstract][Full Text] [Related]
11. Oral treatment of cowpox and vaccinia virus infections in mice with ether lipid esters of cidofovir.
Quenelle DC; Collins DJ; Wan WB; Beadle JR; Hostetler KY; Kern ER
Antimicrob Agents Chemother; 2004 Feb; 48(2):404-12. PubMed ID: 14742188
[TBL] [Abstract][Full Text] [Related]
12. Comparative effects of cidofovir and cyclic HPMPC on lethal cowpox and vaccinia virus respiratory infections in mice.
Smee DF; Bailey KW; Sidwell RW
Chemotherapy; 2003 Jun; 49(3):126-31. PubMed ID: 12815205
[TBL] [Abstract][Full Text] [Related]
13. Activities of certain 5-substituted 4'-thiopyrimidine nucleosides against orthopoxvirus infections.
Kern ER; Prichard MN; Quenelle DC; Keith KA; Tiwari KN; Maddry JA; Secrist JA
Antimicrob Agents Chemother; 2009 Feb; 53(2):572-9. PubMed ID: 19029322
[TBL] [Abstract][Full Text] [Related]
14. Effects of cidofovir on the pathogenesis of a lethal vaccinia virus respiratory infection in mice.
Smee DF; Bailey KW; Wong MH; Sidwell RW
Antiviral Res; 2001 Oct; 52(1):55-62. PubMed ID: 11530188
[TBL] [Abstract][Full Text] [Related]
15. Antiviral activity of the EB peptide against zoonotic poxviruses.
Altmann SE; Brandt CR; Jahrling PB; Blaney JE
Virol J; 2012 Jan; 9():6. PubMed ID: 22225618
[TBL] [Abstract][Full Text] [Related]
16. Effects of cidofovir treatment on cytokine induction in murine models of cowpox and vaccinia virus infection.
Knorr CW; Allen SD; Torres AR; Smee DF
Antiviral Res; 2006 Nov; 72(2):125-33. PubMed ID: 16782209
[TBL] [Abstract][Full Text] [Related]
17. Treatment of lethal vaccinia virus respiratory infections in mice with cidofovir.
Smee DF; Bailey KW; Sidwell RW
Antivir Chem Chemother; 2001 Jan; 12(1):71-6. PubMed ID: 11437324
[TBL] [Abstract][Full Text] [Related]
18. Effects of four antiviral substances on lethal vaccinia virus (IHD strain) respiratory infections in mice.
Smee DF; Wong MH; Bailey KW; Beadle JR; Hostetler KY; Sidwell RW
Int J Antimicrob Agents; 2004 May; 23(5):430-7. PubMed ID: 15120719
[TBL] [Abstract][Full Text] [Related]
19. Vaccinia virus lacking the deoxyuridine triphosphatase gene (F2L) replicates well in vitro and in vivo, but is hypersensitive to the antiviral drug (N)-methanocarbathymidine.
Prichard MN; Kern ER; Quenelle DC; Keith KA; Moyer RW; Turner PC
Virol J; 2008 Mar; 5():39. PubMed ID: 18321387
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of cowpox virus and monkeypox virus infection by mitoxantrone.
Altmann SE; Smith AL; Dyall J; Johnson RF; Dodd LE; Jahrling PB; Paragas J; Blaney JE
Antiviral Res; 2012 Feb; 93(2):305-308. PubMed ID: 22182595
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]